On January 15 and 24, Jianfeng Pharmaceutical Sales Company successively held annual summary meetings for terminals and agents to review the 2016 and deploy the work in 2017.

At the terminal sales summary meeting held on January 15, the managers of each office reported on the work in 2016, summarized the gains and losses of the work, analyzed the existing problems, and exchanged the work plan for the new year. Xu Junxiong, executive deputy general manager of the pharmaceutical sales company, summarized the overall situation of terminal sales from the aspects of sales performance, specific work and existing problems. Focusing on the work focus of "increasing incentives, emphasizing academics and strengthening promotion", he arranged the work in 2017 in terms of incentive mechanism, team building, bidding and bargaining, marketing innovation and academic promotion, and read out the decomposition plan and assessment criteria for 2017 terminal sales targets.

Jin Xuacai, deputy general manager of the pharmaceutical company and general manager of the pharmaceutical sales company, commented on the advantages and disadvantages of terminal sales in 2016 at the meeting. According to the current development trend of the pharmaceutical industry, he asked all offices to seize the opportunity of medical insurance adjustment and increase hospital development. Strengthen communication and visit to achieve sales volume; Increase academic promotion and actively respond to trend changes; Salesmen should strengthen their own training and study and strengthen internal management of the office. Innovating sales mode, do a good job of terminal sales.

At the meeting, the level of salesmen was also evaluated according to their work performance, the collectives and individuals who won the annual sales competition award were commended, and the annual sales responsibility system was signed with each office.

At the agency sales meeting held on January 24, the regional managers summarized and reported the work in the first half of the year from the aspects of product sales, new customer development, existing problems, new year's work and goal realization. Regional managers and managers evaluate the reporter from five aspects, such as enterprise loyalty, sales performance over the years, annual sales performance, and market development ability, and ask questions about the main points of the report.

The meeting discussed and approved a new regional manager incentive and appraisal plan, announced the decision to merge several regions with smaller sales, and conducted a regional manager competition. Participants are ranked by the evaluation scores obtained in the previous report. The top ten regional managers give priority to regional bargaining. After three rounds of bidding, the competition results are finally determined.

Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, analyzed the current situation of the pharmaceutical industry from many aspects at the agency sales meeting, and pointed out the challenges and opportunities. He said that the incentive policy for regional managers will be adjusted, and he hopes that all regions will have a deep understanding of the new policy and resolutely implement it.

Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, attended the agent sales meeting and made a speech. He commented on the agency sales work, pointed out that some personnel have problems such as lack of self-confidence, low morale, few methods, and serious inert thinking. Pharmaceutical sales companies are required to organize various trainings in a targeted manner, and sales personnel should also strengthen learning., Improve their own sales skills, think carefully according to the life cycle and sales strategy of the company's key products, and solve the problems in sales.